GeneBalance Inc., founded in 2009, is a bioscience company that focuses on commercialization of reagents, bioscience supplies and more than 1000 antibodies, production of which are outsourced. GeneBalance also conducts R/D on diagnosis and treatment of neurodegenerative diseases and cancers by targeting abnormal RNA splicing and by monitoring signature chimeric RNA biomarkers. We estimate that annual revenue will reach $100000-200000 in 2012.